The IBN SINA Pharmaceutical Industry Ltd. announced unaudited earnings results for the second quarter and six months ended December 2017. For the quarter, the company reported EPS of BDT 3.77 against BDT 3.59 for October-December, 2016. EPS was BDT 5.95 for July-December, 2017 against BDT 5.11 for July-December, 2016. NOCFPS was BDT 7.80 for July-December, 2017 against Tk. 2.93 for July-December, 2016. NAV per share was BDT 44.12 as on December 31, 2017 and BDT 38.90 as on June 30, 2017.